OGN

#1345
Organon & Co. Common Stock
13.3 7 USD
+9907.49%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
13.37
13.39
Rango anual
0.13
13.48
Cambio diario
+9907.49%
Variación mensual
+0.38%
Variación en los últimos 6 meses
+74.09%
Cambio anual
+84.16%
Cierres anteriores
0.1 3
Open
13.3 7
Mínimo
13.3 7
High
13.3 9
Volumen
1 045
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 3.51 B
  • Employee 10 K
  • Founded N/A
  • CEO N/A
  • Website www.organon.com
  • Headquarter New Jersey, United States
  • FIGI BBG00ZQRGW24
  • Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
6.37
Relación precio/flujo de caja
0.25
Dividendos por acción
0.02
Rendimiento por dividendo, %
6.68

Organon & Co. Common Stock

Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Noticias